Johan Brügemann

1.1k total citations
41 papers, 693 citations indexed

About

Johan Brügemann is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Biomedical Engineering. According to data from OpenAlex, Johan Brügemann has authored 41 papers receiving a total of 693 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Cardiology and Cardiovascular Medicine, 12 papers in Surgery and 6 papers in Biomedical Engineering. Recurrent topics in Johan Brügemann's work include Atrial Fibrillation Management and Outcomes (9 papers), Cardiac pacing and defibrillation studies (8 papers) and Cardiac Arrhythmias and Treatments (8 papers). Johan Brügemann is often cited by papers focused on Atrial Fibrillation Management and Outcomes (9 papers), Cardiac pacing and defibrillation studies (8 papers) and Cardiac Arrhythmias and Treatments (8 papers). Johan Brügemann collaborates with scholars based in Netherlands, Greece and Austria. Johan Brügemann's co-authors include Harry J.G.M. Crijns, Isabelle C. Van Gelder, Dirk J. van Veldhuisen, Cees P. van der Schans, Robert G Tieleman, Hans L. Hillege, Marco Alings, Michiel Rienstra, Marcelle D. Smit and Jan G.P. Tijssen and has published in prestigious journals such as Journal of the American College of Cardiology, European Heart Journal and The American Journal of Cardiology.

In The Last Decade

Johan Brügemann

39 papers receiving 658 citations

Peers

Johan Brügemann
T. Briffa Australia
C Giusti Italy
Ellen C. Keeley United States
A. Rozkovec United Kingdom
Adrian B VanBakel United States
Hafiz Imran United States
Rajiv Saran United States
T. Briffa Australia
Johan Brügemann
Citations per year, relative to Johan Brügemann Johan Brügemann (= 1×) peers T. Briffa

Countries citing papers authored by Johan Brügemann

Since Specialization
Citations

This map shows the geographic impact of Johan Brügemann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johan Brügemann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johan Brügemann more than expected).

Fields of papers citing papers by Johan Brügemann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johan Brügemann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johan Brügemann. The network helps show where Johan Brügemann may publish in the future.

Co-authorship network of co-authors of Johan Brügemann

This figure shows the co-authorship network connecting the top 25 collaborators of Johan Brügemann. A scholar is included among the top collaborators of Johan Brügemann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johan Brügemann. Johan Brügemann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dontje, Manon L., Martje H.L. van der Wal, Ronald P. Stolk, et al.. (2013). Daily Physical Activity in Stable Heart Failure Patients. The Journal of Cardiovascular Nursing. 29(3). 218–226. 88 indexed citations
2.
Riezebos‐Brilman, Annelies, Erik A.M. Verschuuren, Willem J. van Son, et al.. (2013). The clinical course of hepatitis E virus infection in patients of a tertiary Dutch hospital over a 5-year period. Journal of Clinical Virology. 58(3). 509–514. 19 indexed citations
3.
Alings, Marco, Marcelle D. Smit, Harry J.G.M. Crijns, et al.. (2013). Routine versus aggressive upstream rhythm control for prevention of early atrial fibrillation in heart failure: background, aims and design of the RACE 3 study. Netherlands Heart Journal. 21(7-8). 354–363. 21 indexed citations
4.
Brügemann, Johan, Greetje A. Kampinga, Annelies Riezebos‐Brilman, et al.. (2010). Two donor-related infections in a heart transplant recipient: One common, the other a tropical surprise. The Journal of Heart and Lung Transplantation. 29(12). 1433–1437. 19 indexed citations
5.
Jonge, Nicolaas de, J. H. Kirkels, C. Klöpping, et al.. (2008). Guidelines for heart transplantation. Netherlands Heart Journal. 16(3). 79–87. 28 indexed citations
6.
Brügemann, Johan. (2008). Alternatives for heart transplantation?. Netherlands Heart Journal. 16(2). 39–40.
7.
Brügemann, Johan, et al.. (2007). Dobutaminetherapie thuis als brug naar harttransplantatie of als einddoeltherapie bij ernstig hartfalen begeleid door de 'nurse practitioner'. Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank. 151(44). 1 indexed citations
8.
Haelst, Paul L. van, Johan Brügemann, Gilles F.H. Diercks, Albert J.H. Suurmeijer, & Dirk J. van Veldhuisen. (2006). Serial right ventricular endomyocardial biopsy in rapid-onset severe heart failure due to giant cell myocarditis. Cardiovascular Pathology. 15(4). 228–230. 4 indexed citations
9.
Brügemann, Johan, et al.. (2004). Hartrevalidatie bij patiënten met een aangeboren hartafwijking, een implanteerbare defibrillator of chronisch hartfalen.. Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank. 148(37). 1809–1815. 2 indexed citations
10.
Nieuwland, Wybe, Dirk J. van Veldhuisen, Johan Brügemann, et al.. (2000). Differential effects of high-frequency versus low-frequency exercise training in rehabilitation of patients with coronary artery disease. Journal of the American College of Cardiology. 36(1). 202–207. 39 indexed citations
11.
Gelder, I. C. Van, et al.. (1999). Lack of prevention of heart failure by serial electrical cardioversion in patients with persistent atrial fibrillation. Heart. 82(4). 486–493. 21 indexed citations
12.
Brügemann, Johan, et al.. (1995). Thrombolytic therapy of right heart emboli-in-transit. European Respiratory Journal. 8(11). 1834–1837. 3 indexed citations
13.
Brügemann, Johan, Jan van der Meer, Hans L. Hillege, et al.. (1994). Lipoprotein(a) levels in patients with myocardial infarction treated with anistreplase: no prediction of efficacy but inverse correlation with plasminogen activation in non-patency. International Journal of Cardiology. 45(2). 109–113. 10 indexed citations
14.
Bom, V J J, et al.. (1993). Rapid enzyme immunoassay of anti-streptokinase antibodies in human plasma. Clinica Chimica Acta. 218(2). 121–129. 4 indexed citations
15.
Brügemann, Johan, et al.. (1993). Anti-streptokinase antibodies inhibit fibrinolytic effects of anistreplase in acute myocardial infarction. The American Journal of Cardiology. 72(5). 462–464. 22 indexed citations
16.
Brügemann, Johan, et al.. (1992). Logistical problems in prehospital thrombolysis. European Heart Journal. 13(6). 787–788. 13 indexed citations
17.
Brügemann, Johan, et al.. (1991). ANTISTREPTOKINASE ANTIBODIES BEFORE AND ABSENCE OF A SYSTEMIC LYTIC STATE AFTER THROMBOLYTIC THERAPY WITH ANISTREPLASE PREDICT FAILURE OF TREATMENT IN PATIENTS WITH A MYOCARDIAL-INFARCTION. Data Archiving and Networked Services (DANS). 1 indexed citations
18.
Brügemann, Johan, et al.. (1991). SOLID-PHASE ENZYME-IMMUNOASSAY OF ANTISTREPTOKINASE ANTIBODIES IN HUMAN PLASMA. Data Archiving and Networked Services (DANS). 1 indexed citations
19.
Brügemann, Johan, et al.. (1990). Reocclusion three months after successful thrombolytic treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activating complex. The American Journal of Cardiology. 65(22). 1422–1424. 13 indexed citations
20.
Brügemann, Johan, et al.. (1990). A systemic non-lytic state predicts failure of anisoylated plasminogen streptokinase activating complex (APSAC) in acute myocardial infarction. Journal of the American College of Cardiology. 15(2). A3–A3. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026